Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven research firms that are currently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $44.67.
A number of research firms have weighed in on TRUP. Evercore ISI upgraded Trupanion to a "strong-buy" rating in a report on Friday, August 9th. Stifel Nicolaus raised their target price on Trupanion from $30.00 to $40.00 and gave the company a "hold" rating in a research note on Monday, September 23rd. Piper Sandler increased their price objective on Trupanion from $45.00 to $57.00 and gave the stock a "neutral" rating in a research note on Thursday, October 31st. Bank of America raised their price target on Trupanion from $47.00 to $56.00 and gave the stock a "buy" rating in a research note on Friday, September 20th. Finally, Northland Securities increased their price objective on Trupanion from $45.00 to $50.00 and gave the company a "market perform" rating in a report on Thursday, October 31st.
View Our Latest Stock Report on TRUP
Trupanion Trading Up 4.4 %
NASDAQ TRUP traded up $2.25 during trading hours on Tuesday, reaching $52.96. The company had a trading volume of 835,015 shares, compared to its average volume of 682,609. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $2.24 billion, a P/E ratio of -158.47 and a beta of 1.69. The stock has a 50-day moving average of $48.39 and a 200 day moving average of $38.62. Trupanion has a 1-year low of $19.69 and a 1-year high of $57.90.
Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.09. The firm had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The company's revenue for the quarter was up 14.6% on a year-over-year basis. During the same period last year, the company earned ($0.10) earnings per share. As a group, research analysts anticipate that Trupanion will post -0.23 earnings per share for the current fiscal year.
Insider Activity
In other news, Director Murray B. Low sold 2,000 shares of the business's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total value of $105,340.00. Following the sale, the director now directly owns 131,513 shares in the company, valued at $6,926,789.71. The trade was a 1.50 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Fawwad Qureshi sold 624 shares of the business's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. Insiders have sold a total of 10,124 shares of company stock worth $482,981 over the last three months. Corporate insiders own 5.50% of the company's stock.
Institutional Trading of Trupanion
Institutional investors and hedge funds have recently bought and sold shares of the stock. Quest Partners LLC bought a new stake in Trupanion during the third quarter worth about $37,000. GAMMA Investing LLC raised its holdings in Trupanion by 70.4% during the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider's stock worth $61,000 after acquiring an additional 596 shares in the last quarter. Headlands Technologies LLC bought a new stake in Trupanion during the second quarter worth about $162,000. Entropy Technologies LP bought a new stake in Trupanion during the third quarter worth about $202,000. Finally, Mutual of America Capital Management LLC acquired a new position in shares of Trupanion in the third quarter valued at approximately $210,000.
Trupanion Company Profile
(
Get Free ReportTrupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.